Unió Europea -
búlgar -
EMA (European Medicines Agency)
rukobia
viiv healthcare b.v. - fostemsavir trometamol - ХИВ инфекции - Антивирусни средства за системно приложение - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.
Bulgària -
búlgar -
Ecolab
assouplissant desinfectant du linge senteur pomme kiwi
ecolab deutschland gmbh -
Unió Europea -
búlgar -
EMA (European Medicines Agency)
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - Имунни серуми и имуноглобулини - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
Bulgària -
búlgar -
Adama
ЕКЛИПС® 70 ВГ
adama - Вододиспергируеми гранули (ВГ) - 700 г/кг метрибузин - Хербициди
Unió Europea -
búlgar -
EMA (European Medicines Agency)
pylclari
curium pet france - piflufolastat (18f) - Простатни неоплазми - Диагностични радиофармацевтици - Този лекарствен продукт е само за диагностична употреба. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
Unió Europea -
búlgar -
EMA (European Medicines Agency)
aquipta
abbvie deutschland gmbh & co. kg - atogepant - Мигренозни разстройства - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
Unió Europea -
búlgar -
EMA (European Medicines Agency)
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - Антинеопластични средства - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.